Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when OSG files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsOctave Specialty Group reports 51% revenue growth and narrowed losses in Q2 2026
Filed August 6, 2026 · Period ending August 6, 2026 · ~1 min read
Key Changes
-
high
Total revenue grew 51% to $83.0 million; net loss from continuing operations narrowed to $14.4 million from $20.5 million; Adjusted EBITDA to shareholders turned positive at $3.7 million versus a loss of $4.6 million in Q2 2025.
Exhibit 99.1 view on EDGAR → -
high
Insurance Distribution segment revenue up 77% to $58 million with 44% organic growth; net loss to shareholders narrowed to $4 million from $8 million; Adjusted EBITDA to shareholders more than tripled to $10 million from $3 million.
Exhibit 99.1 view on EDGAR → -
high
Everspan (Specialty P&C) combined ratio improved 610 basis points to 100.6% from 106.7%; loss ratio declined to 61.4% from 67.8%; net income rose to $1 million from $0.4 million despite gross premiums written down 2% to $95 million.
Exhibit 99.1 view on EDGAR → -
medium
Launched proprietary AI-driven underwriting platform to convert unstructured submissions into decision-ready risks; management expects the platform to accelerate underwriting decisions and enable faster MGA launches.
Exhibit 99.1 view on EDGAR → -
medium
Stockholders' equity declined to $699 million ($15.52 per share) from $713 million ($15.83 per share) at March 31, 2026, driven by a $12 million total comprehensive loss; holding company net assets at $48 million including $26 million in cash.
Exhibit 99.1 view on EDGAR →
Summary
Octave Specialty Group reported Q2 2026 results showing strong top-line momentum and meaningful progress toward profitability. Consolidated revenue grew 51% to $83.0 million, driven by 77% growth in the Insurance Distribution segment (including 44% organic growth) and the benefits of the 2025 ArmadaCare acquisition.
The company narrowed its net loss from continuing operations to $14.4 million from $20.5 million in the prior year, while Adjusted EBITDA to shareholders swung positive to $3.7 million from a $4.6 million loss. The Everspan specialty P&C insurance segment showed improved underwriting discipline, with the combined ratio improving 610 basis points to 100.6% and the loss ratio declining to 61.4% from 67.8%.
These gains reflect repositioning efforts that began in the second half of 2024. The company also launched a proprietary AI-driven underwriting platform intended to accelerate decision-making and speed new MGA launches, representing a strategic investment in operational capabilities. For retail holders, the quarter demonstrates progress on the path to profitability, though the company remains loss-making and stockholders' equity declined modestly to $15.52 per share from $15.83 per share at quarter-end.
Section-by-Section Diff
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
Gross and net premiums written totaled $95 million and $23 million, down (2)% and up 52%, respectively ... Net income equaled $1 million, compared to $0.4 million in 2Q25 ... Adjusted EBITDA to Shareholders totaled $1.8 million, compared to $0.7 million in 2Q25 ... Loss Ratio 61.4 % 67.8 % (640) bps ... Combined Ratio 100.6 % 106.7 % (610) bps
Everspan reported Q2 2026 gross premiums written of $95 million (down 2% year-over-year) and net premiums written of $23 million (up 52%). Net income improved to $1 million from $0.4 million in Q2 2025, while Adjusted EBITDA to shareholders increased to $1.8 million from $0.7 million. The combined ratio improved by 610 basis points to 100.6%, driven by a loss ratio reduction to 61.4% from 67.8%. Management noted these results reflect ongoing repositioning efforts that began in the second half of 2024.
Added in current filing · view on EDGAR →
Total revenues $ 82,995 $ 54,957 51% ... Net income (loss) from continuing operations attributable to shareholders, net of tax $ (14,429) $ (20,548) NM ... Adjusted EBITDA to shareholders $ 3,685 $ (4,569) NM ... Adjusted net income (loss) attributable to shareholders $ (1,813) $ (10,552) NM
On a consolidated basis, Octave reported Q2 2026 total revenues of $83.0 million, up 51% from $55.0 million in Q2 2025. The net loss from continuing operations attributable to shareholders narrowed to $14.4 million from $20.5 million. Adjusted EBITDA to shareholders turned positive at $3.7 million versus a loss of $4.6 million in the prior year, while Adjusted net loss to shareholders improved to $1.8 million from $10.6 million.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 7, 2026 · How we verify